Sign in
4

Changes in Ownership

Oncotelic Therapeutics, Inc. Filed Acc 0001209191-16-110139

Options or other derivatives

  • Director acquired 99,711 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Pedder Simon Director 2016-03-21 Grant or award · Stock Option (Right to Buy) +99,711 99,711 D
Loading xslF345X03/doc4.xml…